217 GENES FOUND

? »

Limit search: Premium | Premium (Subcell) | Premium (Cell line)

« prev | Page of 5 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HIST1H2AHHistone cluster 1, H2ah
Tissue enriched
HIST1H2BIHistone cluster 1, H2biPlasma proteins
Tissue enhanced
HIST1H2BLHistone cluster 1, H2blPlasma proteins
Tissue enriched
HIST1H2BMHistone cluster 1, H2bm
Tissue enhanced
HIST1H2BOHistone cluster 1, H2bo
Tissue enhanced
HIST1H3AHistone cluster 1, H3a
Tissue enhanced
HIST1H3BHistone cluster 1, H3bCancer-related genes
Tissue enriched
HIST1H3FHistone cluster 1, H3f
Tissue enhanced
HIST1H3HHistone cluster 1, H3h
Tissue enhanced
HK3Hexokinase 3 (white cell)Enzymes
Plasma proteins
Tissue enhanced
HLA-DOBMajor histocompatibility complex, class II, DO betaPredicted membrane proteins
Predicted secreted proteins
Group enriched
ICOSInducible T-cell co-stimulatorCD markers
Disease related genes
Predicted membrane proteins
Tissue enhanced
IFIT1BInterferon-induced protein with tetratricopeptide repeats 1B
Tissue enriched
IGSF21Immunoglobin superfamily, member 21Predicted secreted proteins
Tissue enhanced
IKZF1IKAROS family zinc finger 1 (Ikaros)Cancer-related genes
Disease related genes
Predicted membrane proteins
Transcription factors
Tissue enhanced
IL18RAPInterleukin 18 receptor accessory proteinCD markers
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
IL2RAInterleukin 2 receptor, alphaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
IL2RBInterleukin 2 receptor, betaCancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
IL2RGInterleukin 2 receptor, gammaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
IL4I1Interleukin 4 induced 1Enzymes
Predicted secreted proteins
Tissue enhanced
IRF8Interferon regulatory factor 8Disease related genes
Plasma proteins
Transcription factors
Tissue enhanced
ITGA2BIntegrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)Cancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
ITGAMIntegrin, alpha M (complement component 3 receptor 3 subunit)Cancer-related genes
CD markers
Disease related genes
Predicted membrane proteins
Group enriched
ITGAXIntegrin, alpha X (complement component 3 receptor 4 subunit)CD markers
Predicted membrane proteins
Tissue enhanced
KIF21BKinesin family member 21BPlasma proteins
Tissue enhanced
KLHL15Kelch-like family member 15
Tissue enhanced
KLRC3Killer cell lectin-like receptor subfamily C, member 3Predicted membrane proteins
Tissue enhanced
KLRK1Killer cell lectin-like receptor subfamily K, member 1Cancer-related genes
CD markers
Predicted membrane proteins
Tissue enhanced
LAG3Lymphocyte-activation gene 3CD markers
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
LCKLymphocyte-specific protein tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Tissue enhanced
LCN2Lipocalin 2Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Tissue enhanced
LEF1Lymphoid enhancer-binding factor 1Plasma proteins
Transcription factors
Tissue enhanced
LRMPLymphoid-restricted membrane proteinPredicted membrane proteins
Tissue enhanced
LTBLymphotoxin beta (TNF superfamily, member 3)Cancer-related genes
Plasma proteins
Group enriched
LTFLactotransferrinCancer-related genes
Plasma proteins
Predicted secreted proteins
Tissue enhanced
LY86Lymphocyte antigen 86Predicted secreted proteins
Tissue enhanced
MAP4K1Mitogen-activated protein kinase kinase kinase kinase 1Enzymes
Tissue enhanced
MARCOMacrophage receptor with collagenous structurePlasma proteins
Predicted membrane proteins
Tissue enhanced
MFSD2BMajor facilitator superfamily domain containing 2BPredicted membrane proteins
Tissue enriched
MKI67Marker of proliferation Ki-67Cancer-related genes
Plasma proteins
Tissue enhanced
MLC1Megalencephalic leukoencephalopathy with subcortical cysts 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Group enriched
MMP8Matrix metallopeptidase 8 (neutrophil collagenase)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
MMP9Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
MPOMyeloperoxidaseCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted secreted proteins
Tissue enriched
MS4A1Membrane-spanning 4-domains, subfamily A, member 1CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
MYBL2V-myb avian myeloblastosis viral oncogene homolog-like 2Cancer-related genes
Transcription factors
Tissue enhanced
MYO1GMyosin IG
Tissue enhanced
NCF1Neutrophil cytosolic factor 1Disease related genes
Tissue enhanced
NCF4Neutrophil cytosolic factor 4, 40kDaDisease related genes
Plasma proteins
Tissue enhanced
NFE2Nuclear factor, erythroid 2Transcription factors
Tissue enriched

« prev | Page of 5 | next »